Literature DB >> 23045168

Central pain mechanisms in the rheumatic diseases: future directions.

Kristine Phillips1, Daniel J Clauw.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23045168      PMCID： PMC3610409          DOI： 10.1002/art.37739

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  119 in total

Review 1.  How neuroimaging studies have challenged us to rethink: is chronic pain a disease?

Authors:  Irene Tracey; M Catherine Bushnell
Journal:  J Pain       Date:  2009-11       Impact factor: 5.820

Review 2.  Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms.

Authors:  D J Clauw; G P Chrousos
Journal:  Neuroimmunomodulation       Date:  1997 May-Jun       Impact factor: 2.492

3.  Increased pressure pain sensibility in fibromyalgia patients is located deep to the skin but not restricted to muscle tissue.

Authors:  E Kosek; J Ekholm; P Hansson
Journal:  Pain       Date:  1995-12       Impact factor: 6.961

4.  Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.

Authors:  C Neville; A E Clarke; L Joseph; P Belisle; D Ferland; P R Fortin
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

5.  Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli.

Authors:  Luda Diatchenko; Andrea G Nackley; Gary D Slade; Kanokporn Bhalang; Inna Belfer; Mitchell B Max; David Goldman; William Maixner
Journal:  Pain       Date:  2006-07-11       Impact factor: 6.961

6.  The relationship between psychosocial variables and pain reporting in osteoarthritis of the knee.

Authors:  P Creamer; M C Hochberg
Journal:  Arthritis Care Res       Date:  1998-02

7.  The relationship of anxiety and depression with self-reported knee pain in the community: data from the Baltimore Longitudinal Study of Aging.

Authors:  P Creamer; M Lethbridge-Cejku; P Costa; J D Tobin; J H Herbst; M C Hochberg
Journal:  Arthritis Care Res       Date:  1999-02

8.  Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  J Rheumatol       Date:  2004-04       Impact factor: 4.666

9.  Fibromyalgia syndrome and disease activity in systemic lupus erythematosus.

Authors:  E F Morand; M H Miller; S Whittingham; G O Littlejohn
Journal:  Lupus       Date:  1994-06       Impact factor: 2.911

Review 10.  Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews.

Authors:  Kurt Kroenke; Erin E Krebs; Matthew J Bair
Journal:  Gen Hosp Psychiatry       Date:  2009-03-04       Impact factor: 3.238
View more
  50 in total

1.  Reflecting on pain management for patients with osteoarthritis and other rheumatic disorders: there's more to pain management than managing pain.

Authors:  Danielle Perret; Eric Y Chang; Winnie Pang; Shuntaro Shinada; Richard S Panush
Journal:  Pain Manag       Date:  2013-07

2.  Improvement in the Spatial Distribution of Pain, Somatic Symptoms, and Depression After a Weight Loss Intervention.

Authors:  Andrew Schrepf; Steven E Harte; Nicole Miller; Christine Fowler; Catherine Nay; David A Williams; Daniel J Clauw; Amy Rothberg
Journal:  J Pain       Date:  2017-08-25       Impact factor: 5.820

Review 3.  Reflections on 'older' drugs: learning new lessons in rheumatology.

Authors:  S A Kerrigan; I B McInnes
Journal:  Nat Rev Rheumatol       Date:  2020-02-17       Impact factor: 20.543

Review 4.  Narcotic bowel syndrome and opioid-induced constipation.

Authors:  Eva Szigethy; Marc Schwartz; Douglas Drossman
Journal:  Curr Gastroenterol Rep       Date:  2014-10

5.  Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation.

Authors:  Gabriel Natura; Karl-Jürgen Bär; Annett Eitner; Michael K Boettger; Frank Richter; Susanne Hensellek; Andrea Ebersberger; Johannes Leuchtweis; Takayuki Maruyama; Gunther Olaf Hofmann; Karl-Jürgen Halbhuber; Hans-Georg Schaible
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-31       Impact factor: 11.205

6.  Efficacy of transcranial direct current stimulation over primary motor cortex (anode) and contralateral supraorbital area (cathode) on clinical pain severity and mobility performance in persons with knee osteoarthritis: An experimenter- and participant-blinded, randomized, sham-controlled pilot clinical study.

Authors:  Hyochol Ahn; Adam J Woods; Mark E Kunik; Abhishek Bhattacharjee; Zhiguo Chen; Eunyoung Choi; Roger B Fillingim
Journal:  Brain Stimul       Date:  2017-05-19       Impact factor: 8.955

7.  Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancer.

Authors:  N Lynn Henry; Anna Conlon; Kelley M Kidwell; Kent Griffith; Jeffrey B Smerage; Anne F Schott; Daniel F Hayes; David A Williams; Daniel J Clauw; Steven E Harte
Journal:  J Pain       Date:  2014-01-22       Impact factor: 5.820

8.  Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.

Authors:  Jeffrey M Lackner; Chang-Xing Ma; Laurie Keefer; Darren M Brenner; Gregory D Gudleski; Nikhil Satchidanand; Rebecca Firth; Michael D Sitrin; Leonard Katz; Susan S Krasner; Sarah K Ballou; Bruce D Naliboff; Emeran A Mayer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-21       Impact factor: 11.382

Review 9.  Clinical experience with duloxetine in the management of chronic musculoskeletal pain. A focus on osteoarthritis of the knee.

Authors:  Jacques P Brown; Luc J Boulay
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-12       Impact factor: 5.346

10.  Involvement of Spinal IL-6 Trans-Signaling in the Induction of Hyperexcitability of Deep Dorsal Horn Neurons by Spinal Tumor Necrosis Factor-Alpha.

Authors:  Christian König; Eric Morch; Annett Eitner; Christian Möller; Brian Turnquist; Hans-Georg Schaible; Andrea Ebersberger
Journal:  J Neurosci       Date:  2016-09-21       Impact factor: 6.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.